Cambridge’s Qureight Raises $20M to Build a Chest Foundation Model That Compresses Drug Trial…
One imaging decision that once took two weeks now takes 48 hours. That single number defines why Cambridge's Qureight just closed a $20 million Series B — and why the company's chest foundation model is being watched closely by every pharma…
Read More...
Read More...
